Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study

By sjmartinez • June 22, 2024

Gebauer K, Spelman L, Yamauchi PS, Bagel J, Nishandar T, Crane M, Kopeloff I, Kothekar M, Yao SL, Sofen HL. Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study. J Am Acad Dermatol. 2024 Jul;91(1):91-99. doi: 10.1016/j.jaad.2024.03.025. Epub 2024 Mar 28. PMID: 38554938.

Tags: Dermatology, efficacy, itch, Olive View DoM, psoriasis, Publications, safety, scalp, tildrakizumab

Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African American Women

Jung SY, Pellegrini M, Yu H. Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African[...]

Treatment of Solar Lentigines: A Systematic Review of Clinical Trials

Mardani G, Nasiri MJ, Namazi N, Farshchian M, Abdollahimajd F. Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. J Cosmet Dermatol. 2025 Apr;24(4):e70133.[...]

Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials

Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M. Deucravacitinib: Laboratory Parameters[...]